Denmark is the world champion in digitalization. Combining a rising startup scene, record-breaking investment activity and world-leading research, Denmark is looked to internationally as a source of inspiration and as the place to find high-caliber business and research partners and investment opportunities.

Kim Baden-Kristensen, CEO, Brain+: This type of exposure increases our visibility and brand recognition internationally, which is valuable given our global ambitions. We develop our medical solutions in partnerships with leading international research and clinical institutions, and our strategy of scaling globally is also based on strategic partnerships. Being more widely known and recognized internationally increases our probability of reaching more of the right partners. Digital Hub Denmark also facilitates direct match-making between the Danish tech scene and potential international customers visiting Denmark, which we can benefit from.

Digital Hub Denmark is a public-private partnership between the Danish Government, the Confederation of Danish Industry, the Danish Chamber of Commerce and Finance Denmark. As part of the digital showcase, also called `Founded in Denmark', Digital Hub Denmark selected and interviewed 150 of the best Danish tech startups in nine technology categories: Fintech, HealthTech, Robotics, CreaTech, PropTech, AgroTech, EdTech, AI, Govtech. Brain+ was selected together with 16 other HealthTech Companies, including a wide variety of health technologies like robotics, radiology, and A.I. Based on interviews with each start-up, short showcase videos were made.

Watch the Brain+ digital showcase video here https://vimeo.com/691303530/e3601eee6d

About Digital Hub Denmark

Mission: To make Denmark a leading digital country in Europe. To do so Digital Hub Denmark brands home-grown digital solutions to attract talent, investments and international customers to new scalable tech products and services that are shaping future industries worldwide.

https://digitalhubdenmark.dk/founded-in-denmark/

About BRAIN+ [BRAINP]

PROBLEM: Dementia is a terrible condition, crippling a person's independence and putting a heavy burden also on the family. With an aging population, dementia - and in particular Alzheimer's dementia - is a growing problem, threatening to overwhelm the health care systems of the world. So far, attempts to develop effective drug-based therapies have failed, and focus is shifting towards new non-drug therapies that cane pave the way to help relieve the heavy burden of dementia - for people living with the disease, their relatives and healthcare systems.

VISION. Making effective Alzheimer's and dementia treatments available to everyone, as digital medicine

MISSION: To restore independence and quality of life by treating and detecting cognitive decline in people living withAlzheimer's disease and dementia.

SOLUTION: Together with world-leading experts and institutions, we are digitizing the best-in-class, non-drug dementia therapies, making them available on regular digital devices - both in people's homes and at the clinics. A therapy here, simply means a person having to actively do something, interacting with a software program or another person, which is stimulating to the brain, or which results in changes in behavior that brings measurable health benefits. Our digital therapeutic solutions also benefit the patient care givers in their work and can help ease the pressure on the health care systems.

DIGITAL & DRUGS: Software-as-medical treatments can be used on their own or be combined with traditional drug treatments. We believe the future will combine the best of both the digital and the pharmacological world for mutually enhancing benefits, including synergies in compliance, patient engagement and mechanisms of action for better health outcomes.

PERSONLIZED, DATA-DRIVEN MEDICINE: We believe a key benefit of digital medicine is also to proactively collect and use data to create tailored and more effective personalized therapy experiences, and to help improve clinical and scientific practice, while always adhering to strict ethical standards of personal data protection.

OUR DNA: We are a digital biotech company. Our technologies and products are being built on a deep understanding of the challenges and needs associated with dementia, rigorously tested, scientifically and clinically validated, and regulated as software-as-medical-devices(/treatments). These treatments will be prescribed by health care professionals and paid for by health insurance or state health care.

POTENTIAL: In 2030, the global costs of dementia are expected to be $2 trillion (or equal to 2/3rds of the entire health care budget of the USA), prospectively 1 in 3 people will die from dementia, and the estimated market potential for digital dementia treatments approximately $2-5 billion. Tapping into this market with effective digital solutions has the potential to generate revenue of hundreds of millions $. Brain+ aims to commercialize its products based on licensing deals with strategic commercial partners for faster market penetration and global scaling.

TEAM & TECH: We have built our knowledge base, know-how and network of global expert collaborators over 10 years, and our technology portfolio is the results of R&D investments of over €10 million, which puts us in a unique position to become a global market leader in digital therapeutic solutions for dementia and Alzheimer's. We have a senior management team with a combined 100 years of track-record, with backgrounds from companies such as Coloplast, Lundbeck, Novartis, and GN Hearing. This provides us the solid backbone needed, to change the way we treat and deal with dementia on a global scale.

Read more & watch latest video updates: https://www.brain-plus.com/investor/